Beta Bionics Announces Closing of $57 Million Series C Financing

 Beta Bionics, Inc. — a clinical stage medical technology company committed to the design, development, and commercialization of the iLet® Bionic Pancreas System — today announced the completion of a $57 million Series C equity financing. Proceeds from the financing will support product development, regulatory submissions, and preparations for the commercialization of the insulin dosing […]

Equip Raises $58 Million Series B Funding Round to Revolutionize Eating Disorder Treatment

 Equip, the leading provider of virtual, evidence-based eating disorder treatment in the U.S., today announced a $58M Series B funding round, bringing the company’s total funding to $75M. The Chernin Group (TCG), an early investor in Headspace, led the round and was joined by Tiger Global and General Catalyst, as well as existing investors F-Prime […]